RioGin
Charlottesville
About RioGin
RioGin is an early stage biotechnology company, based in Charlottesville VA, born from a collaboration between Geysen Enterprises and SRI International. RioGin is dedicated to improving the pharmacokinetic properties of peptide drugs without negatively impacting their pharmacodynamic properties. Using their proprietary platform technology, RioGin is advancing patient quality of life through convenient dosing and reduced side effects resulting in better compliance. For their pharma partners RioGin extends patent life, protecting and expanding existing franchises and enables more efficacious drug therapies. They believe with RioGin's platform technology peptide drugs will be able to fully reach their potential and gain their true place in the everyday therapeutic arsenal.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Seed (Apr 2014)
- Website: riogin.com
- Phone: (540) 705-7738
Industries & Categories
Biotechnology, Collaboration, Health Care, Therapeutics
Canonical: https://fsome.com/organization/riogin-2021211 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.